β-Cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 12, 2000, Pages 4434-4440

  Gylling, Mikhail ^a   Tuomi, Tiinamaija ^b   Björses, Petra ^c,d   Kontiainen, Sirkka ^b   Partanen, Jukka ^e   Christie, Michael R ^f   Knip, Mikael ^c   Perheentupa, Jaakko ^c   Miettinen, Aaro ^a,b,g  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^e FINNISH RED CROSS BLOOD SERVICE   (Finland)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 2; IA ANTIBODY; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; INSULIN; ISOENZYME;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CANDIDIASIS; CHILD; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECTODERMAL DYSPLASIA; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ALLELE; AUTOIMMUNE POLYENDOCRINOPATHY; CLINICAL TRIAL; GENE; GENETICS; GLUCOSE TOLERANCE TEST; HAPLOTYPE; IMMUNOLOGY; MIDDLE AGED; PANCREAS ISLET; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ALLELES; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENES, MHC CLASS II; GLUCOSE TOLERANCE TEST; GLUTAMATE DECARBOXYLASE; HAPLOTYPES; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISOENZYMES; MALE; MIDDLE AGED; POLYENDOCRINOPATHIES, AUTOIMMUNE;

EID: 0034351867     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.12.4434     Document Type: Article

References (51)

1. An autosomal locus causing autoimmune disease: Autoimmune polyglandular disease type I assigned to chromosome 21
2. An autoimmume disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. The Finrush-German APECED Consortium
3. Positional cloning of the APECED gene
4. Localization of the APECED protein in distinct nuclear structures
5. The mouse AIRE gene: Comparative genomic sequences, gene organisation, and expression
6. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla
7. AIRE encodes a nuclear protein co-localizing with eytoskeletal filaments: Altered sub-cellular distribution of mutants lacking the PHD zinc fingers
8. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients
9. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients
10. Polyglandular autoimmune syndrome type I among Iranian Jews
11. Autoimmume polyendocrine syndrome type I (APECED)
12. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I
13. Cytochrome P450IA2 and aromatic L-amino acid decarboxylase are hepatic autoantigens in auto-immune polyendocrine syndrome type I
14. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure
15. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies
16. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry
17. Antibodies to islet 37k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity
18. Value of ICA512 antibodies for prediction and diagnosis of type 1 diabetes
19. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmume diseases confers high specificity for insulin-dependent diabetes mellitus
20. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM
21. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512)
22. Islet cell and glutamic acid decarboxylase antibodies and heat-shock protein 65 responses in children with newly diagnosed insulin-dependent diabetes mellitus
23. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes. Combinatorial islet autoantibody workshop
24. High level of concordance between assays for glutamic acid decarboxylase antibodies. First International Glutamic Acid Decarboxylase Antibody Workshop
25. Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes
26. A novel micro-assay for insulin autoantibodies
27. Autoantigens IA-2 and GAD in type I (insulin-dependent) diabetes
28. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus
29. Association between autoantibody markers and subtypes of DR4 and DR4-DQ in Swedish children with insulin-dependent diabetes reveals closer association of tyrosine pyrophosphatase autoimmunity with DR4 than DQ8
30. HLA-DQBI*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM
31. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes
32. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome
33. Although DR3-DQBi*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in β-cell autoimmunity
34. Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease
35. Immune reactivity to glutamic acid decarboxylase 65 in stiff-man syndrome and type 1 diabetes mellitus
36. Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives
37. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes
38. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA)
39. Autoimmunity to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
40. Type 1 diabetes mellitus
41. HLA-DQ β gene contribution to susceptibility and resistance to insulin dependent diabetes mellitus
42. The immunoendocrinopathy syndromes
43. + first degree relatives of patients with type I diabetes expressing the HLA DQBI*0602 allele
44. Association of HLA-DQB1*0201 with stiff-man syndrome
45. Genetics of susceptibility and resistance to insulin-dependent diabetes in stiffman syndrome
46. The role of MHC class II molecules in susceptibility and resistance to autoimmunity
47. A mechanism for the major histocompatibility linked resistance to autoimmunity
48. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T-cells with additional specifities
49. T lymphocyte tolerance: From thymic deletion to peripheral control mechanisms
50. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease